- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05571501
Measuring Normal and Impaired Walking in Children Using the GAITRite Walkway
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary output of the main cohort of typically developing children is the developmental percentile charts.
These will be then used to present the clinical longitudinal data against a normal backdrop of developmental changes in children.
This has multiple clinical applications in many of the children assessed by physiotherapy at GOSH and more widely Nationally and internationally
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, WC1N 3JH
- Great Ormond Street Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to walk 100m
Exclusion Criteria:
- recent fracture or musculoskeletal injury which would affect gait
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Typically developing children
500 children aged 1-18 male and female will be recruited from local schools, after school clubs and playgroups. Each child will complete a screening form following appropriate information and consent process. Each child will then complete the walking assessment which takes 15 minutes in total |
10-20 walking assessment using the GAITRite walkway
Other Names:
|
Active Comparator: Clinical groups
Children will be recruited through their patient journey. Families who consent to participation will complete the screening form and the GAITRite walking assessment as part of their pre-planned clinical followup in outpatient clinics. One group of children will be assessed at one time point, whilst a second group of children with progressive orthopaedic conditions or treatment will be assessed at intervals to give longitudinal data |
10-20 walking assessment using the GAITRite walkway
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait data recorded via GAITRite software
Time Frame: For the duration of the study measured once for typically developing and at multiple clinic visits over 24 months for clinical groups
|
Continuous numeric data summarising walking performance and characteristics
|
For the duration of the study measured once for typically developing and at multiple clinic visits over 24 months for clinical groups
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
demographic and clinical outcome data
Time Frame: 30 to 60 mins to collect relevant data at a single time point, with an update to include additional admissions over 24months
|
surgical history (where relevant)
|
30 to 60 mins to collect relevant data at a single time point, with an update to include additional admissions over 24months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lucy Alderson, PhD, Great Ormond Street Hospital
Publications and helpful links
General Publications
- Wood M, Cleary MA, Alderson L, Vellodi A. Changes in gait pattern as assessed by the GAITRite walkway system in MPS II patients undergoing enzyme replacement therapy. J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S127-35. doi: 10.1007/s10545-009-1103-2. Epub 2009 Mar 25.
- Bladen M, Alderson L, Khair K, Liesner R, Green J, Main E. Can early subclinical gait changes in children with haemophilia be identified using the GAITRite walkway. Haemophilia. 2007 Sep;13(5):542-7. doi: 10.1111/j.1365-2516.2007.01429.x.
- Alderson LM, Joksaite SX, Kemp J, Main E, Watson T, Platt FM, Cortina-Borja M. Age-related gait standards for healthy children and young people: the GOS-ICH paediatric gait centiles. Arch Dis Child. 2019 Aug;104(8):755-760. doi: 10.1136/archdischild-2018-316311. Epub 2019 Mar 25.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10NS14
- 11/LO/1889 (Other Identifier: NRES)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Typically Developing Children
-
Surgical Information Sciences Inc.CompletedSoftware Evaluation for Visualizing Anatomical Structures Not Typically Identified on Clinical MR ImagesUnited States
-
Surgical Information Sciences Inc.CompletedSoftware Evaluation for Visualizing Anatomical Structures That Are Not Typically Identified on Clinical MR Images
-
University of RochesterCompletedLow Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk FactorsUnited States
-
Universitair Ziekenhuis BrusselRecruitingAnalyse Neuromuscular Monitoring for Developing a Model to Predict TOF Ratio During AnesthesiaBelgium
-
Mayo ClinicCompletedTelemedicine | Primary Health Care | Diagnosis | Therapeutics | Developing CountriesHonduras
-
Akdeniz UniversityThe Scientific and Technological Research Council of TurkeyCompletedDeveloping the ABEP-H | Determining the Effect of ABEP-HTurkey
-
Nat Intensive Care Surveillance - MORUUniversity of Oxford; Wellcome Trust; Makerere University; D'Or Institute for Research...Not yet recruitingCritical Illness | Risk Factors | Invasive Mechanical Ventilation | Developing Countries | ICU Mortality
-
Osprey Medical, IncEnrolling by invitationPatients at Risk for Developing Contrast-induced NephropathyUnited States
-
University of CalgaryRecruiting
-
National Human Genome Research Institute (NHGRI)CompletedUndiagnosed Disease | Healthy Volunteer (Adult With Typically Developing Child) | Inherited Neurodegenerative Disorders | Inherited Metabolic Disorders (Inborn Errors of Metabolism) | Alzheimer's Disease and Related DementiasUnited States
Clinical Trials on Gait assessment using the GAITRIte walkway
-
St. Jude Children's Research HospitalTennessee Physical Therapy AssociationCompletedOsteonecrosisUnited States
-
University GhentCompletedValidity | Educational Assessment | Chest Tube InsertionBelgium
-
Medical University of ViennaUniversity of Mississippi Medical CenterCompletedInfertility, Female | Infertility of Tubal Origin | Fallopian Tube Occlusion | Uterus AbnormalAustria
-
University Hospital Inselspital, BerneUniversity of Colorado, Denver; Mayo Clinic; Northwestern University; University... and other collaboratorsUnknownDeglutition Disorders | Esophageal Diseases | EosinophiliaUnited States, Canada, Switzerland, United Kingdom
-
University of AlbertaWithdrawnAsphyxia Neonatorum | Birth AsphyxiaCanada
-
University of EdinburghNot yet recruitingCoronary Artery Disease | Angina, Stable
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
Shalvata Mental Health CenterUnknownDepression | SchizophreniaIsrael
-
Poitiers University HospitalCompletedPostnatal DepressionFrance
-
I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationCystic Fibrosis | Lymphangioleiomyomatosis | COPD | Bronchial Asthma | Hypersensitivity Pneumonitis | Interstitial Lung Diseases | Chronic Respiratory DiseasesRussian Federation